Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1138077]Researchers: Dr Catherine Caldon (Principal investigator)
Brief description ~25% of breast cancer deaths are attributable to cancers that have failed endocrine therapy and recur >5 years after primary diagnosis. These cancers are not well understood because their long latency makes them difficult to study. We have new models of this disease that identify a “therapy tolerant” population, and this is likely to re-emerge to cause late recurrence. Our work could potentially identify new biological tests and therapeutic strategies to treat late recurring breast cancer.
Funding Amount $AUD 456,384.16
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1138077
- PURL : https://purl.org/au-research/grants/nhmrc/1138077
